ArticleNucleic acids research2025
Heterochromatome wide analyses reveal MBD2 as a phase separation scaffold for heterochromatin compartmentalization and composition.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Heterochromatin is essential for nuclear integrity, genome stability, and gene regulation. However, the mechanisms governing heterochromatin compartmentalization remain poorly understood. Recent studies suggest that phase separation underlies the organization of heterochromatin. Here, we integrated quantitative spatial proteomics, phase separation assays, and phase separation prediction tools to identify and characterize candidate phase separation scaffold proteins involved in heterochromatin compartmentalization. We in vitro reconstituted phase-separated heterochromatin condensates using heterochromatin fractions isolated from mouse brain. Mass spectrometric analysis yielded around 1000 proteins from which 250 were predicted to have scaffold phase separation properties using machine learning-based phase separation protein prediction tools. From these, 20 proteins, including methyl-CpG binding domain protein 2 (MBD2), were localized to pericentric heterochromatin compartments using gene ontology annotation analysis. We demonstrated that MBD2 undergoes liquid-liquid phase separation via C-terminus-mediated homo-oligomerization, forming liquid-like condensates that regulate heterochromatin compartmentalization. Moreover, we found that MBD2a and MBD2b exclude histone acetyltransferases (e.g. Kat7) and recruit histone deacetylases (e.g. HDAC11, GATAD2b) at pericentric heterochromatin, resulting in subsequent deacetylation of histone H3 K27 and K9 within heterochromatin. This study advances our understanding of heterochromatin compartmentalization and highlights the role of MBD2 in heterochromatin dynamics and composition functionally regulating chromatin states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.